Suppr超能文献

皮肤血管增生。第二部分。增生与良性肿瘤。

Cutaneous vascular proliferation. Part II. Hyperplasias and benign neoplasms.

作者信息

Requena L, Sangueza O P

机构信息

Department of Dermatology, Fundación Jiménez Díaz, Universidad Autónoma, Madrid, Spain.

出版信息

J Am Acad Dermatol. 1997 Dec;37(6):887-919; quiz 920-2. doi: 10.1016/s0190-9622(97)70065-3.

Abstract

This second part of our review about vascular proliferations summarizes the clinicopathologic features of the cutaneous vascular hyperplasias and benign neoplasms. Hyperplasias comprise a heterogeneous group of vascular proliferations that eventually show a tendency to regression. Angiolymphoid hyperplasia with eosinophilia is included within the group of hyperplasias because of its historical denomination and its reactive nature, probably as a consequence of an arteriovenous shunt, although usually the lesions do not regress. Pyogenic granuloma, bacillary angiomatosis, intravascular papillary endothelial hyperplasia, and pseudo-Kaposi's sarcoma qualify as vascular hyperplasias because they regress when the stimulus that initiated them is removed. Benign neoplasms form a large group of hemangiomas with distinctive clinicopathologic characteristics, although some of them are of recent description and may produce diagnostic difficulties. We classified cutaneous benign vascular neoplasms according to their cell lineage of differentiation, for example, endothelial, glomus cell, and pericytic differentiation. Subsequent categories are established according to the size of the involved vessels (capillaries, venules and arterioles, or veins and arteries) or the nature of the proliferating vessels (blood or lymphatic vessels). Capillary and cavernous hemangiomas have been the terms classically used to name the most common variants of benign vascular neoplasms (i.e., infantile hemangiomas), but they are not the most appropriate denominations for these lesions. First, these names are not contrasting terms. Furthermore, most of the socalled "cavernous" hemangiomas are not hemangiomas (neoplasms) at all, but venous malformations. The most important conceptual issue is that, at any point in time, a particular hemangioma has its own histopathologic pattern throughout the depth of the lesion. For these reasons, we classified hemangiomas into superficial and deep categories. Some of the lesions reviewed have been recently described in the literature, and they may histopathologically mimic lesions of Kaposi's sarcoma; these include targetoid hemosiderotic hemangioma, microvenular hemangioma, tufted hemangioma, glomeruloid hemangioma, kaposiform hemangioendothelioma, spindle-cell hemangioendothelioma, and benign lymphangioendothelioma. In each of these lesions, we update and emphasize those clinical and histopathologic features that are helpful for differential diagnosis with lesions of authentic Kaposi's sarcoma in any of its three stages of development (patch, plaque, or nodule).

摘要

我们关于血管增生的综述的第二部分总结了皮肤血管增生和良性肿瘤的临床病理特征。增生包括一组异质性的血管增生,最终显示出消退的趋势。嗜酸性粒细胞增多性血管淋巴样增生因其历史命名和反应性本质被纳入增生组,可能是动静脉分流的结果,尽管通常病变不会消退。化脓性肉芽肿、杆菌性血管瘤、血管内乳头状内皮增生和假性卡波西肉瘤属于血管增生,因为当引发它们的刺激因素去除后,它们会消退。良性肿瘤构成了一大类具有独特临床病理特征的血管瘤,尽管其中一些是最近才被描述的,可能会产生诊断困难。我们根据皮肤良性血管肿瘤的细胞分化谱系进行分类,例如内皮、球旁细胞和周细胞分化。随后根据受累血管的大小(毛细血管、小静脉和小动脉,或静脉和动脉)或增生血管的性质(血管或淋巴管)建立类别。毛细血管性血管瘤和海绵状血管瘤一直是经典的术语,用于命名良性血管肿瘤最常见的变体(即婴儿血管瘤),但它们并不是这些病变最合适的名称。首先,这些名称不是对比性术语。此外,大多数所谓的“海绵状”血管瘤根本不是血管瘤(肿瘤),而是静脉畸形。最重要的概念问题是,在任何时间点,特定的血管瘤在病变的整个深度都有其自身的组织病理学模式。出于这些原因,我们将血管瘤分为浅表和深部类别。综述中的一些病变最近在文献中被描述,它们在组织病理学上可能模仿卡波西肉瘤的病变;这些病变包括靶样含铁血黄素性血管瘤、微静脉性血管瘤、丛状血管瘤、肾小球样血管瘤、卡波西样血管内皮瘤、梭形细胞血管内皮瘤和良性淋巴管内皮瘤。在这些病变中,我们更新并强调那些有助于与处于任何三个发展阶段(斑片、斑块或结节)的真性卡波西肉瘤病变进行鉴别诊断的临床和组织病理学特征。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验